Stocklytics Platform
Asset logo for symbol SCPH
Scpharmaceuticals
SCPH52
$3.74arrow_drop_up4.16%$0.14
Penny Stock
Asset logo for symbol SCPH
SCPH52

$3.74

arrow_drop_up4.16%

Performance History

Chart placeholder
Key Stats
Open$3.62
Prev. Close$3.60
EPS-1.95
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$187.15M
PE Ratio-
LOWHIGH
Day Range3.55
3.82
52 Week Range3.08
6.71
Ratios
EPS-1.95

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Scpharmaceuticals (SCPH)

Scpharmaceuticals Inc (SCPH) is a pharmaceutical company that focuses on developing and commercializing transformative pharmaceutical products for subcutaneous delivery. The company's mission is to improve patient care by making non-oral therapies possible for diseases that currently have only oral options. SCPH is headquartered in Burlington, Massachusetts and was founded in 2013.
The stock price history of Scpharmaceuticals Inc (SCPH) shows a mix of volatility and steady growth. In its early years, the stock experienced significant price fluctuations, but in recent years, it has shown more stability. As of the latest available data, the stock is trading at $10.50 per share.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. John H. Tucker
Headquarters
Burlington
Employees
96
Exchange
NASDAQ
add Scpharmaceuticals  to watchlist

Keep an eye on Scpharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Scpharmaceuticals 's (SCPH) price per share?

The current price per share for Scpharmaceuticals (SCPH) is $3.74. The stock has seen a price change of $0.15 recently, indicating a 4.17% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Scpharmaceuticals (SCPH)?

For Scpharmaceuticals (SCPH), the 52-week high is $6.71, which is 79.41% from the current price. The 52-week low is $3.08, the current price is 21.43% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Scpharmaceuticals (SCPH) a growth stock?

Scpharmaceuticals (SCPH) has shown an average price growth of -2.69% over the past three years. It has received a score of 46 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Scpharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Scpharmaceuticals (SCPH) stock price performance year to date (YTD)?

As of the latest data, Scpharmaceuticals (SCPH) has a year-to-date price change of -41.47%. Over the past month, the stock has experienced a price change of -14.42%. Over the last three months, the change has been -27.38%. Over the past six months, the figure is -1.71%. Looking at a longer horizon, the five-year price change stands at -12.21%.
help

Is Scpharmaceuticals (SCPH) a profitable company?

Scpharmaceuticals (SCPH) has a net income of -$54.81M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 71.96% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -180.99% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $13.59M, although specific revenue growth data is currently not available. The gross profit is $9.78M. Operating income is noted at -$55.4M. Furthermore, the EBITDA is -$63.67M.
help

What is the market capitalization of Scpharmaceuticals (SCPH)?

Scpharmaceuticals (SCPH) has a market capitalization of $187.15M. The average daily trading volume is 3.75, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level